Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomesCollaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomes

L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomes.

AUSTIN, Texas & MINNEAPOLIS–(BUSINESS WIRE)–L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives across the life sciences and food industries. The partnership is designed to help organizations accelerate innovation, modernize operations, and achieve measurable business outcomes, while maintaining speed, scale, and execution certainty.

Life sciences enterprises are under mounting pressure to move faster while navigating fragmented data environments, complex regulatory requirements, and growing expectations around AI adoption. Yet many struggle to find partners who can pair strategic vision with real-world execution velocity. Clients are increasingly demanding speed, scale, and substance, and this teaming agreement is purpose-built to deliver exactly that.

By combining L7 Informatics’ unified, AI-ready data platform (L7|ESP) with Turnberry’s business-outcome-first, cloud-exclusive digital services model, the two companies will provide clients with an integrated path from data foundation to enterprise impact. Together, they will support large, multi-site implementations, predictable deployments, and faster time-to-value across research, development, and manufacturing environments.

“Life sciences organizations don’t need more disconnected tools or abstract roadmaps; they need a unified platform and a partner who can execute with precision,” said Mark Spencer, President & CEO of L7 Informatics. “Turnberry brings a rare combination of delivery certainty, deep life sciences expertise, and enterprise-scale execution. This partnership strengthens our ability to help customers eliminate data silos, become truly AI-ready, and turn scientific data into operational and clinical advantage.”

L7 Informatics’ L7|ESP platform replaces fragmented LIMS, ELN, MES, and scheduling systems with a single, ontology-driven solution that contextualizes data at the point of capture and orchestrates end-to-end workflows. The result is a unified, AI-ready data foundation that accelerates drug development, reduces operational friction, and enables advanced analytics and machine learning, without requiring a disruptive rip-and-replace of existing systems.

Turnberry Solutions redefines digital services through a delivery-certainty-driven approach that combines boutique agility with global scale. Serving seven of the world’s top ten pharmaceutical companies, Turnberry helps life sciences organizations advance patient outcomes through simplification, optimization, digital health, advanced AI, and regulatory-aware transformation.

“Our clients expect outcomes, not experiments,” said Bill Ravenscroft, CEO of Turnberry Solutions. “L7’s platform solves one of the hardest problems in life sciences, creating a true unified, contextualized data that works at enterprise scale. Together, we can move clients from ambition to execution faster, with the confidence that what we design can be delivered, scaled, and sustained.”

The Teaming Agreement reinforces L7 Informatics’ collaborative partner model, enabling certified partners to design, configure, and implement L7|ESP to meet exacting scientific and operational requirements. For customers, the partnership delivers faster deployments, predictable results, stronger pre-sales alignment, and broader access to enterprise transformation initiatives.

As life sciences organizations race to modernize and operationalize AI, L7 Informatics and Turnberry Solutions are positioning themselves as a powerful alliance, one that unites platform innovation with execution excellence to help clients move faster, smarter, and with confidence.

About L7 Informatics

L7 Informatics provides a unified digital platform that eliminates data silos across pharmaceutical, biotech, CDMO, diagnostics, and research organizations. Its L7|ESP platform contextualizes data at the source and orchestrates workflows across research, development, and manufacturing, creating an AI-ready foundation for enterprise-scale innovation. L7 has been recognized by Frost & Sullivan as the Global Leader in Innovation for Pharmaceutical and Biotech LIMS and has appeared on the Deloitte Technology Fast 500 for four consecutive years.

About Turnberry Solutions

Turnberry Solutions is a global digital services company that helps organizations achieve measurable business outcomes through a cloud-exclusive, delivery-certainty-driven model. With deep expertise in life sciences, Turnberry partners with leading enterprises to simplify complexity, accelerate innovation, and deliver transformation at scale.

Contacts

Media Contacts:
Jessica Tobey

L7 Informatics, Inc.

info@L7informatics.com

Ashley Belisle

Turnberry Solutions, Inc.

PR@Turnberrysolutions.com

Market Opportunity
Cyberlife Logo
Cyberlife Price(LIFE)
$0,0273
$0,0273$0,0273
-1,44%
USD
Cyberlife (LIFE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

PayPal Launches Stablecoin on Tron, Avalanche & 6 More Blockchains

PayPal Launches Stablecoin on Tron, Avalanche & 6 More Blockchains

Payments giant PayPal is broadening the reach of its stablecoin, PayPal USD (PYUSD), by integrating it across eight additional blockchains, primarily through LayerZero’s Stargate Hydra bridge. This move aims to create a permissionless and fully fungible version of PYUSD, dubbed PYUSD0, which will facilitate seamless interoperability across multiple blockchain networks. The supported chains include Tron, [...]
Share
Crypto Breaking News2025/09/19 09:33
Will 2026 Be Another Pro-Crypto Year Under Trump 2.0?

Will 2026 Be Another Pro-Crypto Year Under Trump 2.0?

SEC Commissioner Caroline Crenshaw’s departure leaves the agency without a Democratic voice, strengthening Republican control and clearing the path for a more crypto
Share
Blockhead2026/01/09 19:30
India joins global push for safe AI in healthcare

India joins global push for safe AI in healthcare

The post India joins global push for safe AI in healthcare appeared on BitcoinEthereumNews.com. Homepage > News > Business > India joins global push for safe AI in healthcare India has joined the HealthAI Global Regulatory Network (GRN) as a pioneer member, marking a significant step in its efforts to ensure the safe, effective, and ethical use of artificial intelligence (AI) in healthcare. HealthAI, the Global Agency for Responsible AI in Health, hailed India’s inclusion as a critical milestone in its mission to strengthen international cooperation around responsible AI governance in health systems. The agreement launches a new collaboration between India and HealthAI, focused on sharing safety protocols, clinical monitoring practices, and regulatory insights to accelerate the global adoption of trustworthy AI in healthcare. India will be represented by the Indian Council of Medical Research – National Institute for Research in Digital Health and Data Science (ICMR-NIRDHDS) and IndiaAI. These agencies will work alongside regulatory counterparts from countries like the United Kingdom and Singapore to shape global standards, monitor AI performance in clinical settings, and contribute to developing safe and equitable digital health technologies. This partnership positions India as a global leader in digital health and responsible AI deployment, enabling it to contribute its technical expertise to the evolving global regulatory landscape. As AI tools become increasingly embedded in healthcare delivery, ensuring their safety, equity, and effectiveness has become urgent. “Through this collaboration with HealthAI, we are fostering cross-disciplinary engagement and strengthening data-driven practice. Together, we aim to enhance the safety, effectiveness and accessibility of AI in health,” Mona Duggal, director of ICMR-NIRDHDS, said in a statement. “The country’s vast healthcare experience and commitment to digital innovation will provide valuable insights as we work together to create global networks that aim to ensure AI-driven benefits reach patients safely and effectively. We welcome India as a founding pioneer country and look forward to the expertise…
Share
BitcoinEthereumNews2025/09/19 13:00